Medical information Clinical review pending

Cytogenetics

Immunohistochemistry Neurofilament Polypeptide Test

A specialized test using immunohistochemistry to detect neurofilament proteins in tumor tissue, aiding in cancer diagnosis and classification.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Tumor tissue submitted in 10% Formal-saline OR Formalin fixed paraffin embedded block. A copy of the Histopathology report, site of biopsy, and clinical history must be provided.
Results: Sample Daily by 6 pm; Report Block: 5 days; Tissue Biopsy: 5 days; Tissue large complex: 7 days. Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. Ensure the laboratory receives the tumor tissue sample along with the necessary clinical information (Histopathology report, site of biopsy, clinical history).

Test priceKSh 6,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Neurofilament Polypeptide Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Diagnosis of specific tumor types.
✓Classification of tumors.
✓Assisting in treatment planning for cancer.
✓Evaluating tumor tissue samples.
✓Investigating neurological symptoms potentially related to tumors.

In plain language

What this test helps you understand

This test aids in the diagnosis and classification of certain types of tumors by detecting neurofilament proteins within tissue samples. It provides valuable information for oncologists and pathologists to guide treatment planning and patient management.

The Immunohistochemistry Neurofilament Polypeptide Test is a diagnostic procedure used to examine tumor tissues. It employs immunohistochemistry techniques to identify neurofilament proteins, which are markers associated with certain types of cancers. Detecting these proteins helps healthcare providers understand the nature of the cancer and guide treatment decisions. This test specifically measures the presence of neurofilament polypeptides in tumor biopsies. Neurofilaments are structural components found in nerve cells, and their presence in a tumor sample can provide valuable information for diagnosis and management. Patients with symptoms suggestive of cancer, a family history of cancer, or those requiring monitoring after treatment may be advised to undergo this test. The results help differentiate between various tumor types and assist oncologists in choosing appropriate treatment strategies. Discuss your results with your healthcare provider for a complete understanding.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Ensure the laboratory receives the tumor tissue sample along with the necessary clinical information (Histopathology report, site of biopsy, clinical history).

SampleTumor tissue submitted in 10% Formal-saline OR Formalin fixed paraffin embedded block. A copy of the Histopathology report, site of biopsy, and clinical history must be provided.

MethodologyImmunohistochemistry (IHC) technique used to detect neurofilament polypeptides in tissue sections.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific proteins and may not be conclusive for all types of cancer. Results must be interpreted in conjunction with clinical findings, imaging, and other laboratory tests. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Immunohistochemistry (IHC) is a laboratory technique that uses antibodies to detect specific proteins within tissue samples.

Neurofilaments are structural proteins found in nerve cells (neurons). Their presence in tumor tissue can be an indicator of certain cancer types.

This test helps doctors diagnose and classify certain types of cancer by identifying specific markers in the tumor tissue, which guides treatment decisions.

A sample of the tumor tissue, either in formalin-saline or as a formalin-fixed paraffin-embedded block, is required. Clinical history and pathology reports are also needed.

Turnaround time varies depending on the sample type, typically ranging from 5 to 7 days. Confirm with the laboratory before booking.

You can book the test by calling or WhatsApping us at +254711564616. Our team will assist you with the process.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp